BMRA - BIOMERICA INC
3.58
0.120 3.352%
Share volume: 10,238
Last Updated: 05-09-2025
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$3.46
0.12
0.03%
Summary score
19%
Profitability
8%
Dept financing
8%
Liquidity
75%
Performance
20%
Sector
Manufacturing
Industry
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-10.71%
Return on assets
-8.17%
Return on sales
-42.4%
Return on invested capital
216.31%
Total debt ratio
21.92%
Debt ratio change over timeo
0%
Current Ratio
5.52%
Quick Ratio
3.27%
Cash Position Ratio
1.75%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-11.41%
Return on assets
-7.49%
Return on sales
-67.78%
Return on invested capital
-89.26%
Total debt ratio
32.06%
Debt ratio change over timeo
0%
Current Ratio
5.64%
Quick Ratio
4.03%
Cash Position Ratio
2.85%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-13.11%
Return on assets
-10.42%
Return on sales
-144.81%
Return on invested capital
-169.87%
Total debt ratio
20.84%
Debt ratio change over time
0%
Current Ratio
7.28%
Quick Ratio
5.01%
Cash Position Ratio
3.87%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BMRA | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | -10.71% | -440.43% | 31.03% | 4.64% |
| Return on assets | -8.17% | 7.49% | 3.24% | 4.35% |
| Return on sales | -42.4% | 22.38% | 12.93% | 19.99% |
| Return on invested capital | 216.31% | 34.57% | 7.56% | 5.98% |
| Profitability | 25% | 54% | 51% | 41% |
| Total debt ratio | 21.92% | 97.16% | 90.34% | 47.07% |
| Debt ratio change over time | 0% | 0% | 10.66% | 0% |
| Dept financing | 6% | 25% | 48% | 12% |
| Current Ratio | 5.64% | 1.15% | 2.54% | 2.05% |
| Quick Ratio | 4.03% | 0.81% | 2.07% | 1.58% |
| Cash Position Ratio | 2.85% | 0.19% | 1.3% | 0.5% |
| Liquididy | 75% | 13% | 55% | 58% |
| Short-term ratios | BMRA | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | -11.41% | 60.65% | 2.33% | 12.63% |
| Return on assets | -7.49% | 7.96% | 0.9% | 10.75% |
| Return on sales | -67.78% | 23.77% | 1.86% | 40.65% |
| Return on invested capital | -89.26% | 23.12% | 1.54% | 18.65% |
| Profitability | 0% | 83% | 6% | 75% |
| Total debt ratio | 32.06% | 87.29% | 56.37% | 36.76% |
| Debt ratio change over time | 0% | 0% | 4.57% | 0% |
| Dept financing | 9% | 25% | 41% | 11% |
| Current Ratio | 5.64% | 1.15% | 2.54% | 2.05% |
| Quick Ratio | 4.03% | 0.81% | 2.07% | 1.58% |
| Cash Position Ratio | 2.85% | 0.19% | 1.3% | 0.5% |
| Liquididy | 75% | 12% | 36% | 23% |
